A detailed history of Captrust Financial Advisors transactions in In Mode Ltd. stock. As of the latest transaction made, Captrust Financial Advisors holds 11,774 shares of INMD stock, worth $199,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,774
Previous 12,954 9.11%
Holding current value
$199,569
Previous $236,000 15.68%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.43 - $19.06 $18,207 - $22,490
-1,180 Reduced 9.11%
11,774 $199,000
Q2 2024

Aug 14, 2024

SELL
$17.02 - $21.0 $3,761 - $4,641
-221 Reduced 1.68%
12,954 $236,000
Q1 2024

May 15, 2024

SELL
$20.45 - $26.49 $221,780 - $287,284
-10,845 Reduced 45.15%
13,175 $284,000
Q4 2023

Feb 14, 2024

SELL
$19.02 - $30.13 $216,295 - $342,638
-11,372 Reduced 32.13%
24,020 $534,000
Q3 2023

Nov 14, 2023

BUY
$30.46 - $46.04 $223,881 - $338,394
7,350 Added 26.21%
35,392 $1.08 Million
Q2 2023

Aug 14, 2023

SELL
$31.57 - $37.73 $21,120 - $25,241
-669 Reduced 2.33%
28,042 $1.05 Million
Q1 2023

May 15, 2023

BUY
$29.72 - $41.45 $853,290 - $1.19 Million
28,711 New
28,711 $917,000
Q2 2022

Aug 16, 2022

BUY
$20.97 - $37.47 $1,551 - $2,772
74 Added 10.57%
774 $17,000
Q1 2022

May 16, 2022

BUY
$34.38 - $65.77 $9,695 - $18,547
282 Added 67.46%
700 $26,000
Q4 2021

Feb 14, 2022

BUY
$63.78 - $97.86 $15,179 - $23,290
238 Added 132.22%
418 $30,000
Q3 2021

Nov 16, 2021

BUY
$45.58 - $88.24 $2,051 - $3,970
45 Added 33.33%
180 $29,000
Q2 2021

Aug 16, 2021

SELL
$34.4 - $48.34 $68 - $96
-2 Reduced 1.46%
135 $13,000
Q1 2021

May 17, 2021

BUY
$23.17 - $38.3 $46 - $76
2 Added 1.48%
137 $10,000
Q2 2020

Aug 14, 2020

BUY
$9.68 - $17.5 $1,306 - $2,362
135 New
135 $4,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.41B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.